Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
AB

ABBV

Market Closed

AbbVie Inc.

NYSEHealthcareDrug Manufacturers - General
US
57.00K employees
CEO: Robert A. Michael
Founded: 2013
$295.03
+$0.00(+NaN%)
Market Cap
521.50B
Beta
0.28
52W Range
N/A
Dividend Yield
2.35%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: AbbVie trades significantly above its PERT-weighted fair value ($294.98 vs. $163.87), indicating potential overvaluation with high downside risk (100% Monte Carlo scenarios below current price). Strong leverage and growth contrast with weak profitability and liquidity scores, highlighting financial strain despite expansion. Valuation dispersion and volatility (37.36% coefficient of variation) suggest elevated investment risk.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore ABBV

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

ABBV in the Healthcare

Mega Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - General

Browse industry stocks →